Overview

* Aspen Aerogels ( ASPN ) Q2 revenue falls to $78 mln from $117.8 mln year-over-year

* Net loss of $9.1 mln includes $5.9 mln in restructuring charges

* Adjusted EBITDA improves 98% quarter-over-quarter, reflecting cost structure reductions

Outlook

* Aspen sees H2 2025 revenue between $140 mln and $160 mln

* Company expects FY 2025 revenue of $297 mln to $317 mln

* Aspen projects H2 2025 Adjusted EBITDA of $20 mln to $30 mln

* Company plans to maintain net cash position by year-end

Result Drivers

* COST STRUCTURE REDUCTIONS - Aspen attributes 98% improvement in adjusted EBITDA QoQ to reductions in fixed cost structure

* THERMAL BARRIER GROWTH - Thermal barrier segment revenue increased 13% QoQ, contributing to overall performance

* ENERGY INDUSTRIAL DECLINE - Energy industrial segment revenue decreased 24% QoQ, impacting total revenue

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS -$0.11

Q2 Net -$9.10

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy"

* Wall Street's median 12-month price target for Aspen Aerogels Inc ( ASPN ) is $9.50, about 13.3% above its August 6 closing price of $8.24

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)